Stewart Appelrouth - SEC Form 4 Insider Trading Activity

Summary

Updated Aug 3, 2026

Stewart Appelrouth is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market purchases: $18K. Historical track record: 1/5 stars across 3 tracked purchases.

Profile

Stewart Appelrouth is Director at AIM ImmunoTech Inc. (AIM). Appelrouth has reported 4 insider filings with the SEC since 2024. The most recent filing was in December 2024.

RoleDirector
Notability26/100

Board memberships

Reported roles

Track Record

InsiderAlpha computes a forward-return-based score for every insider with enough Form 4 purchase history. The metrics below reflect realised performance after each tracked open-market purchase.

InsiderAlpha rating★☆☆☆☆ (1/5)
Total purchases tracked3
Purchases with forward-return data3
30-day win rate0%
90-day win rate0%
Avg 5-day return+3.81%
Avg 30-day return-1.67%
Avg 90-day return-40.26%
Best 30-day return+0.00%

Trading Pattern

InsiderAlpha's records for Stewart Appelrouth go back to 2024: 4 primary Form 4 filings, an average of 1.3 per year. The typical open-market purchase is $6K (3 buys totaling $18K). The largest single buy on record is $16K of AIM in 2024. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.

Career & Filing History

Every role Stewart Appelrouth has reported on a Form 4, reconstructed from the filings themselves - reporting insiders must state their relationship to the issuer (officer title, director seat, or 10% ownership) on every filing.

Recent Transactions

DateTickerCompanyCodeSharesPriceValue
2024-12-17AIMAIM ImmunoTech Inc.A - Grant or award24.5K$0.21$5K
2024-12-04AIMAIM ImmunoTech Inc.P - Open-market purchase11.1K$0.21$2K
2024-12-04AIMAIM ImmunoTech Inc.P - Open-market purchase1$0.21$0
2024-12-03AIMAIM ImmunoTech Inc.A - Grant or award22.6K$0.23$5K
2024-11-21AIMAIM ImmunoTech Inc.P - Open-market purchase82.0K$0.19$16K

Most Active Insiders Right Now

Stewart Appelrouth has no recent co-filers at the same companies, so here are the insiders with the largest open-market activity across the market in the last 90 days.

More Notable Insiders

Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:

Frequently Asked Questions

Who is Stewart Appelrouth?

Stewart Appelrouth is Director at AIM ImmunoTech Inc. (AIM). Appelrouth has reported 4 insider filings with the SEC since 2024. The most recent filing was in December 2024.…

Has Stewart Appelrouth been buying or selling stock?

Recorded transactions: 3 open-market purchases ($18K) and 0 open-market sales across all tracked filings.

How accurate is Stewart Appelrouth's historical track record?

Across 3 tracked purchases, Stewart Appelrouth averaged -1.7% avg 30-day return with a 0% 30-day win rate. InsiderAlpha rates the track record at 1/5 stars.

Where can I see all of Stewart Appelrouth's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

Open the live Stewart Appelrouth profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.